Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass

od Takasaki, Hirotaka, Yamamoto, Wataru, Ishii, Yoshimi, Takahashi, Hiroyuki, Watanabe, Reina, Harada, Taishi, Kawasaki, Rika, Hashimoto, Chizuko, Motomura, Shigeki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Sakai, Rika
izdano v Indian J Hematol Blood Transfus (2014)

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

od Tomita, Naoto, Tokunaka, Mami, Nakamura, Naoya, Takeuchi, Kengo, Koike, Junki, Motomura, Shigeki, Miyamoto, Ko, Kikuchi, Ako, Hyo, Rie, Yakushijin, Yoshihiro, Masaki, Yasufumi, Fujii, Soichiro, Hayashi, Takamasa, Ishigatsubo, Yoshiaki, Miura, Ikuo
Izdano 2009

MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy

od Yamamoto, Eri, Tomita, Naoto, Sakata, Seiji, Tsuyama, Naoko, Takeuchi, Kengo, Nakajima, Yuki, Miyashita, Kazuho, Tachibana, Takayoshi, Takasaki, Hirotaka, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Harano, Hiroshi, Motomura, Shigeki, Ishigatsubo, Yoshiaki
izdano v Cancer Sci (2013)